Answers are grounded in this paper and cite their sources.
New ACC–AHA guidelines represent a substantial departure from previous recommendations for lipid management and may have a major effect on clinical practice. Overall, they will move treatment toward statins and deemphasize other agents for a broader range of patients.
No takes yet. Share an insight, caveat, or question.
Keaney et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: